These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 30833451)
21. Chemotherapeutic inhibitors of the enzymes of the de novo pyrimidine pathway. Kensler TW; Cooney DA Adv Pharmacol Chemother; 1981; 18():273-352. PubMed ID: 6119898 [No Abstract] [Full Text] [Related]
22. carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (cad) regulates Notch signaling and vascular development in zebrafish. Coxam B; Neyt C; Grassini DR; Le Guen L; Smith KA; Schulte-Merker S; Hogan BM Dev Dyn; 2015 Jan; 244(1):1-9. PubMed ID: 25294789 [TBL] [Abstract][Full Text] [Related]
23. CAD gene sequence and the domain structure of the mammalian multifunctional protein CAD. Evans DR; Bein K; Guy HI; Liu X; Molina JA; Zimmermann BH Biochem Soc Trans; 1993 Feb; 21(1):186-91. PubMed ID: 8095469 [No Abstract] [Full Text] [Related]
24. Immunochemical analysis of the domain structure of CAD, the multifunctional protein that initiates pyrimidine biosynthesis in mammalian cells. Grayson DR; Lee L; Evans DR J Biol Chem; 1985 Dec; 260(29):15840-9. PubMed ID: 2866187 [TBL] [Abstract][Full Text] [Related]
25. New mechanisms of gene amplification in drug resistance (the episome model). Von Hoff DD Cancer Treat Res; 1991; 57():1-11. PubMed ID: 1686710 [No Abstract] [Full Text] [Related]
26. Chromosome aberrations associated with CAD gene amplification in Chinese hamster cultured cells. Ottaggio L; Agnese C; Bonatti S; Cavolina P; De Ambrosis A; Degan P; Di Leonardo A; Miele M; Randazzo R; Abbondandolo A Mutat Res; 1988 May; 199(1):111-21. PubMed ID: 2896299 [TBL] [Abstract][Full Text] [Related]
27. Appearance of CAD activity, the rate-limiting enzyme for pyrimidine biosynthesis, as B cells progress into and through the G1 stage of the cell cycle. Morford G; Davidson JN; Snow EC Cell Immunol; 1994 Oct; 158(1):96-104. PubMed ID: 7916269 [TBL] [Abstract][Full Text] [Related]
28. Key enzymes in the biosynthesis of purines and pyrimidines: their regulation by allosteric effectors and by phosphorylation. Carrey EA Biochem Soc Trans; 1995 Nov; 23(4):899-902. PubMed ID: 8654862 [No Abstract] [Full Text] [Related]
29. Tumorigenicity and gene amplification potentials of cyclin D1-overexpressing NIH3T3 cells. Asano K; Sakamoto H; Sasaki H; Ochiya T; Yoshida T; Ohishi Y; Machida T; Kakizoe T; Sugimura T; Terada M Biochem Biophys Res Commun; 1995 Dec; 217(3):1169-76. PubMed ID: 8554573 [TBL] [Abstract][Full Text] [Related]
30. Pyrimidine Biosynthetic Enzyme CAD: Its Function, Regulation, and Diagnostic Potential. Li G; Li D; Wang T; He S Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638594 [TBL] [Abstract][Full Text] [Related]
31. 1-beta-D-arabinofuranosylcytosine enhancement of resistance to several antineoplastic drugs in mammalian tissue culture cells. Goz B; Carl PL; Tlsty TD Mol Pharmacol; 1989 Sep; 36(3):360-5. PubMed ID: 2571071 [TBL] [Abstract][Full Text] [Related]
32. Structural Insight into the Core of CAD, the Multifunctional Protein Leading De Novo Pyrimidine Biosynthesis. Moreno-Morcillo M; Grande-García A; Ruiz-Ramos A; Del Caño-Ochoa F; Boskovic J; Ramón-Maiques S Structure; 2017 Jun; 25(6):912-923.e5. PubMed ID: 28552578 [TBL] [Abstract][Full Text] [Related]
33. Micronuclei formation with chromosome breaks and gene amplification caused by Vpr, an accessory gene of human immunodeficiency virus. Shimura M; Onozuka Y; Yamaguchi T; Hatake K; Takaku F; Ishizaka Y Cancer Res; 1999 May; 59(10):2259-64. PubMed ID: 10344725 [TBL] [Abstract][Full Text] [Related]
34. Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors. Ng BG; Wolfe LA; Ichikawa M; Markello T; He M; Tifft CJ; Gahl WA; Freeze HH Hum Mol Genet; 2015 Jun; 24(11):3050-7. PubMed ID: 25678555 [TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells. Khan S; Abdelrahim M; Samudio I; Safe S Endocrinology; 2003 Jun; 144(6):2325-35. PubMed ID: 12746293 [TBL] [Abstract][Full Text] [Related]
36. Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures. Lee JS; Adler L; Karathia H; Carmel N; Rabinovich S; Auslander N; Keshet R; Stettner N; Silberman A; Agemy L; Helbling D; Eilam R; Sun Q; Brandis A; Malitsky S; Itkin M; Weiss H; Pinto S; Kalaora S; Levy R; Barnea E; Admon A; Dimmock D; Stern-Ginossar N; Scherz A; Nagamani SCS; Unda M; Wilson DM; Elhasid R; Carracedo A; Samuels Y; Hannenhalli S; Ruppin E; Erez A Cell; 2018 Sep; 174(6):1559-1570.e22. PubMed ID: 30100185 [TBL] [Abstract][Full Text] [Related]
37. The propensity for gene amplification: a comparison of protocols, cell lines, and selection agents. Sharma RC; Schimke RT Mutat Res; 1994 Jan; 304(2):243-60. PubMed ID: 7506368 [TBL] [Abstract][Full Text] [Related]
38. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Livingstone LR; White A; Sprouse J; Livanos E; Jacks T; Tlsty TD Cell; 1992 Sep; 70(6):923-35. PubMed ID: 1356076 [TBL] [Abstract][Full Text] [Related]
39. Substitutions in the aspartate transcarbamoylase domain of hamster CAD disrupt oligomeric structure. Qiu Y; Davidson JN Proc Natl Acad Sci U S A; 2000 Jan; 97(1):97-102. PubMed ID: 10618377 [TBL] [Abstract][Full Text] [Related]
40. Half of Saccharomyces cerevisiae carbamoyl phosphate synthetase produces and channels carbamoyl phosphate to the fused aspartate transcarbamoylase domain. Serre V; Guy H; Penverne B; Lux M; Rotgeri A; Evans D; Hervé G J Biol Chem; 1999 Aug; 274(34):23794-801. PubMed ID: 10446140 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]